ES8602800A1 - Un procedimiento compuesto de espiro 2h-1,4-benzodioxepin-3 (5h)4'-piperidina y -3'-pirrolidina - Google Patents

Un procedimiento compuesto de espiro 2h-1,4-benzodioxepin-3 (5h)4'-piperidina y -3'-pirrolidina

Info

Publication number
ES8602800A1
ES8602800A1 ES540841A ES540841A ES8602800A1 ES 8602800 A1 ES8602800 A1 ES 8602800A1 ES 540841 A ES540841 A ES 540841A ES 540841 A ES540841 A ES 540841A ES 8602800 A1 ES8602800 A1 ES 8602800A1
Authority
ES
Spain
Prior art keywords
straight chain
chain alkyl
group
branched
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES540841A
Other languages
English (en)
Other versions
ES540841A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Hoechst Roussel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharmaceuticals Inc filed Critical Hoechst Roussel Pharmaceuticals Inc
Publication of ES8602800A1 publication Critical patent/ES8602800A1/es
Publication of ES540841A0 publication Critical patent/ES540841A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/48—Oxygen atoms attached in position 4 having an acyclic carbon atom attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
    • C07D321/02—Seven-membered rings
    • C07D321/10—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C07D491/113—Spiro-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

UN PROCEDIMIENTO PARA PREPARAR COMPUESTOS DE ESPIRO 2H-1,4-BENZODIOXEPIN-3(5H)4-PIPERIDINA Y 3-PIRROLIDINA DE FORMULA (I).CONSISTE EN HIDROLIZAR UN COMPUESTO DE FORMULA (I) EN DONDE R1 ES UN GRUPO DE FORMULA (II), PARA FORMAR UN COMPUESTO DE FORMULA (I) Y OPCIONALMENTE PREPARAR DE MANERA CONOCIDA LAS SALES FARMACEUTICAS CORRESPONDIENTES.APLICADO EN EL TRATAMIENTO DE LA HIPERTENSION Y COMO ANALGESICOS.
ES540841A 1982-08-20 1985-03-01 Un procedimiento compuesto de espiro 2h-1,4-benzodioxepin-3 (5h)4'-piperidina y -3'-pirrolidina Granted ES540841A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/410,155 US4405631A (en) 1982-08-20 1982-08-20 Spiro[2H-1,4-benzodioxepin-3(5H)4'-piperidine and -3'pyrrolidine] compounds and their use as antihypertensive agents

Publications (2)

Publication Number Publication Date
ES8602800A1 true ES8602800A1 (es) 1985-12-01
ES540841A0 ES540841A0 (es) 1985-12-01

Family

ID=23623465

Family Applications (2)

Application Number Title Priority Date Filing Date
ES525013A Granted ES525013A0 (es) 1982-08-20 1983-08-18 Un procedimiento para preparar compuestos de espiro (2h-1,4-benzodioxepin-3(5h)4'-piperidina y -3'-pirrolidina)
ES540841A Granted ES540841A0 (es) 1982-08-20 1985-03-01 Un procedimiento compuesto de espiro 2h-1,4-benzodioxepin-3 (5h)4'-piperidina y -3'-pirrolidina

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES525013A Granted ES525013A0 (es) 1982-08-20 1983-08-18 Un procedimiento para preparar compuestos de espiro (2h-1,4-benzodioxepin-3(5h)4'-piperidina y -3'-pirrolidina)

Country Status (20)

Country Link
US (1) US4405631A (es)
EP (1) EP0102034B1 (es)
JP (1) JPS5953489A (es)
KR (1) KR840005729A (es)
AT (1) ATE33656T1 (es)
AU (1) AU576473B2 (es)
CA (1) CA1210764A (es)
DE (1) DE3376327D1 (es)
DK (1) DK381983A (es)
ES (2) ES525013A0 (es)
FI (1) FI832959A (es)
GR (1) GR78667B (es)
HU (1) HU191874B (es)
IL (1) IL69525A0 (es)
MA (1) MA19881A1 (es)
NO (1) NO833001L (es)
NZ (1) NZ205320A (es)
PH (1) PH18839A (es)
PT (1) PT77223B (es)
ZA (1) ZA836127B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4521537A (en) * 1982-08-20 1985-06-04 Hoechst-Roussel Pharmaceuticals Incorporated Spiro[2H-1,4-benzodioxepin-3(5H)4'-piperidine and -3'-pyrrolidine] compounds and their use as antihypertensive agents
US4472580A (en) * 1982-08-20 1984-09-18 Hoechst-Roussel Pharmaceuticals Incorporated Spiro (2H-1,4-benzodioxepin-3 (5H)4-piperidine and -3-pyrrolidine) compounds and their use as anti-hypertensive agents
US4751223A (en) * 1986-10-14 1988-06-14 Hoechst-Roussel Pharmaceuticals, Inc. Antiinflammatory and analgesic aminoalkyl tetracyclic benzodiazepines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1312894A (fr) * 1962-01-29 1962-12-21 Geigy Ag J R Nouveaux composés hétérocycliques à 2 atomes d'oxygène dans le cycle et leur préparation
CH469736A (de) * 1966-06-28 1969-03-15 Geigy Ag J R Verfahren zur Herstellung von neuen Heterospiroalkanen
US3679666A (en) * 1969-04-03 1972-07-25 Hoffmann La Roche 4-(4-hydroxypiperidino)-4'-fluorobutyrophenones

Also Published As

Publication number Publication date
AU576473B2 (en) 1988-09-01
IL69525A0 (en) 1983-11-30
PT77223B (en) 1986-03-18
MA19881A1 (fr) 1984-04-01
DK381983A (da) 1984-02-21
EP0102034A1 (en) 1984-03-07
ES8505685A1 (es) 1985-06-01
NO833001L (no) 1984-02-21
AU1816983A (en) 1984-02-23
KR840005729A (ko) 1984-11-16
PH18839A (en) 1985-10-10
CA1210764A (en) 1986-09-02
ES525013A0 (es) 1985-06-01
EP0102034B1 (en) 1988-04-20
FI832959A (fi) 1984-02-21
FI832959A0 (fi) 1983-08-18
DE3376327D1 (en) 1988-05-26
ES540841A0 (es) 1985-12-01
JPS5953489A (ja) 1984-03-28
HU191874B (en) 1987-04-28
DK381983D0 (da) 1983-08-19
ZA836127B (en) 1984-04-25
NZ205320A (en) 1987-05-29
GR78667B (es) 1984-09-27
ATE33656T1 (de) 1988-05-15
US4405631A (en) 1983-09-20
PT77223A (en) 1983-09-01

Similar Documents

Publication Publication Date Title
ES2173074T3 (es) Derivados de xantina, procedimiento para su preparacion y su uso farmaceutico.
FI791908A (fi) 1-fenyl-2-aminoetanolderivat
RU92004336A (ru) Водорастворимые производные камптотецина, способ их получения, фармацевтическая композиция, способ ингибирования энзима топоизомеразы, промежуточные продукты
AR004706A1 (es) Un compuesto derivado de benzoxazina y pirido-oxazina utiles como antimicrobianos, composicion farmaceutica que lo contienen, un metodo para preparar dichos compuestos e intermediarios utiles para dicho metodo.
ATE94061T1 (de) Arylsubstituierte aminderivate verwendbar in der krebstherapie.
KR930703319A (ko) 키산틴 유도체
ES534505A0 (es) Un procedimiento para la preparacion de compuestos de 1, 4-dihidropiridina
AR007108A1 (es) Agentes antitumorales y antivirales alquilantes, procedimiento para su preparacion, utilizacion de los mismos para la fabricacion de un medicamento y composicion farmaceutica que contiene a dichos agentes.
ES8602800A1 (es) Un procedimiento compuesto de espiro 2h-1,4-benzodioxepin-3 (5h)4'-piperidina y -3'-pirrolidina
ES472290A1 (es) Un procedimiento para preparar un compuesto de benceno di- sustituido en orto
RU99115829A (ru) Новые аналоги камптотецина, их применение в качестве лекарственных средств и содержащие их фармацевтические композиции
ZA868834B (en) New pyridine compounds with basic substituents,a process for their preparation,medicaments containing them,and their use
ES8603474A1 (es) Procedimiento para preparar derivados de pirazol 1,5-a-piridina
ES8202003A1 (es) Un procedimiento para la preparacion de derivados de ergoli-na
ES8702380A1 (es) Procedimiento para preparar un derivado de (imina ciclica)- difenil-eter
GB1008470A (en) New cyanacetamide derivatives
BR9711948A (pt) Composto processo para produzir um composto composi-Æo farmac-utica e uso de um composto
IL91541A0 (en) Aryloxy-,arylthio-,heteroaryloxy-,and heteroarylthioalkenylene derivatives of amines,their preparation and pharmaceutical compositions containing them
ES2010225A6 (es) Procedimiento de preparacion de nuevos derivados de piperazina diona-2,6.
GB1085101A (en) Substituted oxomorphanthridines
GB1078266A (en) Substituted oxomorphanthridines
ES324894A1 (es) Procedimiento para la preparacion de nuevos derivados de acridano.
HUP9802950A1 (hu) Hidroximsavszármazékok alkalmazása vírusellenes hatású gyógyászati készítmények előállítására
UA37177C2 (uk) Гетероциклічні сполуки або їх фармацевтично прийнятні адитивні солі кислоти або n-оксид гетероциклічної сполуки або його адитивна сіль кислоти
TH58858A (th) ไพราโซโลไพริมิดิโนนสำหรับรักษาอาการเสื่อมสมรรถภาพทางเพศ